Abstract: To provide a receiving device and a receiving method which achieve iterative decoding regarding concatenated codes containing a convolutional code while suppressing increase in circuit scale, a decoder and an error correcting part iteratively perform decoding and error correction corresponding to a convolutional code on soft-decision inputs corresponding to the received signal sequence. Depending on whether a decoding result matches error corrected decoded data obtained in previous processing or not, penalties are calculated corresponding to branches transiting with the respective decoded results, and a branch metric is calculated by reflecting the calculated penalties as to decrease likelihood ratio of each of the branches to which the penalties are to be added. The obtained branch metric is input to a decoder, thereby reflecting the penalty corresponding to the decoding result.

Abstract: A color table editing apparatus includes an image data input unit configured to input image data, a color table selection unit configured to select a given color table from a plurality of color tables in association with the input image data, an initial color data generation unit configured to generate initial color data from the selected color table and representative color data including a plurality of predetermined colors, a target color data editing unit configured to edit the initial color data to generate target color data, an optimized color data generation unit configured to generate optimized color data by performing optimization processing based on a color gamut of the edited target color data, and a user interface image display unit configured to display on a 2-dimensional color plane a user interface image including the target color data and optimized color data.

Abstract: Novel 2-oxo-imidazolidine derivative of the formula: ##STR1## wherein R.sup.1 is lower alkyl or phenyl-lower alkyl, R.sup.2 is lower alkyl, R.sup.3 is alkyl of one to 12 carbon atoms or phenyl-lower alkyl and R.sup.4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salts thereof are disclsoed. Said compounds (I) and salts thereof are useful as hypotensive agents.

Abstract: A 2-oxoimidazolidine derivative of the formula: ##STR1## wherein R.sup.1 is lower alkyl or phenyl-lower alkyl and R.sup.2 is lower alkyl or phenyl, and a process for preparation thereof are disclosed. Said 2-oxoimidazolidine derivative (I) or a pharmaceutically acceptable salt thereof is useful as a hypotensive agent.

Abstract: A tetrahydroisoquinoline compound of the formula: ##STR1## wherein R.sup.1 is alkyl of one to six carbon atoms, cycloalkyl of three to six carbon atoms, allyl or propargyl, R.sup.2 is hydrogen or alkyl of one to six carbon atoms, and R.sup.3 is hydrogen, alkyl of one to six carbon atoms or benzyl. Methods for preparing the compound (I) are disclosed. The compound (I) and a pharmaceutically acceptable salt thereof are useful as a diagnostic or therapeutic agent for angiotensin-related hypertension.

Abstract: A compound of the formula: ##STR1## wherein R.sup.1 is hydrogen or methyl, is prepared by condensing a compound of the formula: ##STR2## wherein R.sup.2 is alkyl, aryl or aralkyl and R.sup.1 is same as above, or a reactive derivative thereof with 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid or an ester thereof to give a compound of the formula: ##STR3## wherein R.sup.3 is an ester residue and R.sup.1 and R.sup.2 are same as above, followed by hydrolysis or ammonolysis of said compound (IV). The compound (I) is useful as a diagnostic or therapeutic agent for angiotensin-related hypertension.